X

Vous n'êtes pas connecté

Maroc Maroc - ZACKS.COM - All Stories - 21/Jun 12:30

Is It Wise to Hold Bio-Rad (BIO) Stock in Your Portfolio Now?

Bio-Rad's (BIO) robust digital PCR business and Clinical Diagnostics segment raise optimism. However, macro issues raise concerns.

Articles similaires

Sorry! Image not available at this time

Is It Apt to Hold Quest Diagnostics (DGX) Stock for Now?

zacks.com - 26/Jun 12:35

Strength in the core business bodes well for Quest Diagnostics (DGX). However, mounting debt levels and reduced COVID-19 testing revenues pose...

Sorry! Image not available at this time

Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now

zacks.com - 26/Jun 11:44

Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

Sorry! Image not available at this time

Is it Wise to Hold Teleflex (TFX) Stock in Your Portfolio Now?

zacks.com - 28/Jun 12:35

Teleflex (TFX) holds strong momentum in the Interventional arm and a favorable solvency. Yet, macroeconomic impacts and competitive environment...

Sorry! Image not available at this time

Is It Wise to Retain Host Hotels (HST) Stock in Your Portfolio?

zacks.com - 27/Jun 15:16

Host Hotels (HST) is poised to benefit from the improvement in the group business and a gradual recovery in business transient, though macroeconomic...

Sorry! Image not available at this time

Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now

zacks.com - 02/Jul 15:56

PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.

Sorry! Image not available at this time

Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now

zacks.com - 02/Jul 15:56

PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.

Sorry! Image not available at this time

Is it Wise to Retain Welltower (WELL) Stock in Your Portfolio?

zacks.com - 03/Jul 16:01

Welltower (WELL) is likely to benefit from the rise in senior citizens' healthcare spending, restructuring initiatives and capital-recycling efforts....

Sorry! Image not available at this time

Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now

zacks.com - 21/Jun 17:37

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.

Sorry! Image not available at this time

Reasons Why You Should Hold Roper (ROP) in Your Portfolio Now

zacks.com - 03/Jul 12:56

Roper (ROP) gains from solid momentum in its businesses, acquired assets and shareholder-friendly moves. However, rising operating costs and high...

Sorry! Image not available at this time

Reasons to Retain Revvity (RVTY) Stock in Your Portfolio Now

zacks.com - 03/Jul 11:39

Revvity's (RVTY) strong product portfolio raises optimism about the stock.